{"identifier":"nobleid:/w1/20260526/E38393D2","arkIdentifier":"ark:/48914/w1/20260526/E38393D2","version":1,"workTitle":"A Multicenter, Randomized, Open-label, Phase II Study to Evaluate the Efficacy and Safety of Erlotinib Versus Etoposide Plus Cisplatin With Concurrent Radiotherapy in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) With Activating Mutation of Epidermal Growth Factor Receptor (EGFR) in Exon 19 or 21","workType":"Journal Article","authors":"Jinming Yu, PhD, Shenglin Ma, PhD, Conghua Xie, PhD, Ming Chen, PhD, Gang Wu, PhD, Jianhua Wang, PhD, Jiancheng Li, PhD, Zhengfei Zhu, PhD, You Lu, PhD, Lvhua Wang, PhD","description":null,"workUrl":null,"existingDoi":null,"createdAt":"2026-05-26T03:13:23.062518Z","canonicalUrl":"https://nobleid.org/ark:/48914/w1/20260526/E38393D2.v1"}